CL

Chin Lee

Chief Medical Officer / Biotech Executive

Lycia Therapeutics

San Francisco, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Lycia Therapeutics
Industry
research
Employees
51.0
Seniority
C suite
Annual Revenue
2600000.0
Total Funding
226600000.0
Latest Funding
Series C

Technologies

Outlook Flywheel Lever Remote

Keywords

biotechnology research lytac extracellular protein degradation therapeutics autoimmune diseases inflammatory diseases modular design targeted protein degradation biotechnology catalytac immunoglobulin e graves disease loss of function drug discovery rare diseases customized therapeutics disease-causing proteins one-size-fits-all new treatment options antibody therapy protein binder internalizing receptor lysosomal recycling novel therapeutics bioorthogonal chemistry scientific collaborations clinical trials preclinical data therapeutic pipelines disease area focus biological targets target protein specificity & potency patients' lives dysregulated proteins precision medicine biopharmaceuticals tissue-specific targeting pharmaceutical development drug candidates biologics therapeutic modalities phd team research & development clinical operations partnerships life-changing impact patient-centric solutions therapeutic innovations scientific advisory board health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans